#GoldenCross $GNMK at 6.96 R9 HiLo 65% T1Y 10 none fwdPE -13.4 DIV N/A #GenMark Di #stocks #trading #finance #market

2019-03-15
51 Views

Golden Cross detected for GNMK (GenMark Diagnostics,) at the close price of 6.96. Trading at a 65 % level between the 52week High (8.81) and 52week Low (3.58). The average analyst 1-year target price is 10.0 with an average none and a score of 0.0.

Golden Cross 9 % GNMK 6.96
GenMark Diagnostics, HiLo 64.6 %
Support 6.96 Resistance 7.78
50DMA 6.44 200DMA 6.41
52week high 8.81 52week low 3.58
10DMA 7.23 20DMA 7.14
100 Mean 5.66
Volume 425806 AvgDayVol 438871
MarketCap 393047904 EBITDA -40684000
Revenue 70759000 PE 0.00
P2S 5.55 P2B 0.00
Dividend 0.00 Div Ex-Date

Further research links:

Marketwatch Yahoo Finance Google Finance StockTwits

You may be interested

#Levermann #ASIA  #BigCap #Buy WK20 $0688.HK (4)
Asia, BigCap, Bull
24 views
Asia, BigCap, Bull
24 views

#Levermann #ASIA #BigCap #Buy WK20 $0688.HK (4)

Andreas Aigner - 2019-05-20

TOP CAPs for #Levermann #ASIA #BigCap #Buy WK20 $0688.HK (4)

#Levermann #EU  #BigCap #Buy WK20 $ALV.DE (7), $EOAN.DE (5), $LGEN.L (4), $HNR1.DE (4)
BigCap, Bull, Europe
21 views
BigCap, Bull, Europe
21 views

#Levermann #EU #BigCap #Buy WK20 $ALV.DE (7), $EOAN.DE (5), $LGEN.L (4), $HNR1.DE (4)

Andreas Aigner - 2019-05-20

TOP CAPs for #Levermann #EU #BigCap #Buy WK20 $ALV.DE (7), $EOAN.DE (5), $LGEN.L (4), $HNR1.DE (4)

#Levermann #EU  #BigCap #Sell WK20 $DTE.DE (0), $BAYN.DE (-4), $ADS.DE (0), $BMW.DE (-2), $CON.DE (0), $EVK.DE (0)
Bear, BigCap, Europe
24 views
Bear, BigCap, Europe
24 views

#Levermann #EU #BigCap #Sell WK20 $DTE.DE (0), $BAYN.DE (-4), $ADS.DE (0), $BMW.DE (-2), $CON.DE (0), $EVK.DE (0)

Andreas Aigner - 2019-05-20

TOP CAPs for #Levermann #EU #BigCap #Sell WK20 $DTE.DE (0), $BAYN.DE (-4), $ADS.DE (0), $BMW.DE (-2), $CON.DE (0), $EVK.DE (0)

Leave a Comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

We use Cookies to improve our Site. Your are agreeing to this by continuing to use our Site.